FR0013426004 - Common Stock

We assign a fundamental rating of **4** out of 10 to **CLA**. **CLA** was compared to 93 industry peers in the **Software** industry. There are concerns on the financial health of **CLA** while its profitability can be described as average. **CLA** scores decently on growth, while it is valued quite cheap. This could make an interesting combination.

In the past year **CLA** had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: **CLA** reported negative net income in multiple years.

Each year in the past 5 years **CLA** had a positive operating cash flow.

The **Return On Assets** of **CLA** (**-1.71%**) is worse than **67.47%** of its industry peers.

The **Average Return On Invested Capital** over the past 3 years for **CLA** is in line with the industry average of **11.87%**.

The last **Return On Invested Capital** (**55.60%**) for **CLA** is above the 3 year average (**13.37%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.71% | ||

ROE | N/A | ||

ROIC | 55.6% |

ROA(3y)-1.22%

ROA(5y)-5.39%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)13.37%

ROIC(5y)10.65%

Looking at the **Operating Margin**, with a value of **7.12%**, **CLA** is in line with its industry, outperforming **49.40%** of the companies in the same industry.

With a **Gross Margin** value of **27.33%**, **CLA** is not doing good in the industry: **86.75%** of the companies in the same industry are doing better.

In the last couple of years the **Gross Margin** of **CLA** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 7.12% | ||

PM (TTM) | N/A | ||

GM | 27.33% |

OM growth 3Y21.32%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.27%

GM growth 5Y0.82%

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so **CLA** is creating value.

Compared to 1 year ago, **CLA** has a worse debt to assets ratio.

The **Altman-Z score** of **CLA** (**0.81**) is worse than **77.11%** of its industry peers.

The Debt to FCF ratio of **CLA** is **5.92**, which is a neutral value as it means it would take **CLA**, **5.92** years of fcf income to pay off all of its debts.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | N/A | ||

Debt/FCF | 5.92 | ||

Altman-Z | 0.81 |

ROIC/WACC8.2

WACC6.78%

A Current Ratio of **0.58** indicates that **CLA** may have some problems paying its short term obligations.

Looking at the **Current ratio**, with a value of **0.58**, **CLA** is doing worse than **95.18%** of the companies in the same industry.

With a **Quick ratio** value of **0.52**, **CLA** is not doing good in the industry: **95.18%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.58 | ||

Quick Ratio | 0.52 |

The **Earnings Per Share** has grown by an impressive **73.45%** over the past year.

Looking at the last year, **CLA** shows a decrease in **Revenue**. The Revenue has decreased by **-2.84%** in the last year.

Measured over the past years, **CLA** shows a very strong growth in **Revenue**. The Revenue has been growing by **25.71%** on average per year.

EPS 1Y (TTM)73.45%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%134.84%

Revenue 1Y (TTM)-2.84%

Revenue growth 3Y7.41%

Revenue growth 5Y25.71%

Sales Q2Q%-4.35%

Based on estimates for the next years, **CLA** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **410.87%** on average per year.

The **Revenue** is expected to grow by **3.93%** on average over the next years.

EPS Next Y4483.33%

EPS Next 2Y927.41%

EPS Next 3Y410.87%

EPS Next 5YN/A

Revenue Next Year-0.29%

Revenue Next 2Y2.71%

Revenue Next 3Y3.93%

Revenue Next 5YN/A

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The **Price/Earnings Ratio** is negative for **CLA**. In the last year negative earnings were reported.

With a **Price/Forward Earnings** ratio of **5.97**, the valuation of **CLA** can be described as very cheap.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **CLA** indicates a rather cheap valuation: **CLA** is cheaper than 98.80% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 5.97 |

Based on the **Enterprise Value to EBITDA** ratio, **CLA** is valued cheaper than 93.98% of the companies in the same industry.

Based on the **Price/Free Cash Flow** ratio, **CLA** is valued cheaply inside the industry as 98.80% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 4.28 | ||

EV/EBITDA | 3.43 |

A more expensive valuation may be justified as **CLA**'s earnings are expected to grow with **410.87%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y927.41%

EPS Next 3Y410.87%

No dividends for **CLA**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**CLARANOVA SE**

EPA:CLA (7/12/2024, 7:00:00 PM)

**1.91**

**+0 (+0.1%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap108.38M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 5.97 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.71% | ||

ROE | N/A | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 7.12% | ||

PM (TTM) | N/A | ||

GM | 27.33% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.69

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | N/A | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.58 | ||

Quick Ratio | 0.52 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)73.45%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y4483.33%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-2.84%

Revenue growth 3Y7.41%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y